GSK126, an EZH2 inhibitor, was found to induce apoptosis in MM cells in a mitochondrial pathway-dependent manner, characterized by cleavage of MCL-1 by active caspase-3 [19]. Here, EZH2 is linked to Miyoshi myopathy.